MatthewSBlockMDPhD

PubMed

• Image-guided tumor ablation in gynecologic oncology: Review of interventional oncology techniques and case examples highlighting a collaborative, multidisciplinary pro...
  Michael R. Moynagh, Sean C. Dowdy, Brian T. Welch, Gretchen E. Glaser, John J. Schmitz, Aminah Jatoi, Carrie L. Langstraat, Matthew S. Block, A. Nicholas Kurup, Amanik...> ;Gynecologic Oncology. 2020 Dec 30
• A Phase 1b Study Evaluating the Safety, Tolerability, and Immunogenicity of CMB305, a Lentiviral-Based Prime-Boost Vaccine Regimen, in Patients with Locally Advanced, ...
  Neeta Somaiah, Sant P. Chawla, Matthew S. Block, John C. Morris, Khanh Do, Joseph Kim, Mihaela Druta, K. K. Sankhala, Patrick Hwu, Robin L. Jones, Sacha Gnjatic, Seung...> ;OncoImmunology. 2020 Nov 19
• Th17-inducing autologous dendritic cell vaccination promotes antigen-specific cellular and humoral immunity in ovarian cancer patients.
  Block, M. S., Dietz, A. B., Gustafson, M. P., Kalli, K. R., Erskine, C. L., Youssef, B., Vijay, G. V., Allred, J. B., Pavelko, K. D., Strausbauch, M. A., Lin, Y., Grud...> ;Nature communications. 2020 Oct 16
• Phase II trial of ribociclib and letrozole in patients with relapsed oestrogen receptor-positive ovarian or endometrial cancers.
  Gerardo Colon-Otero, Valentina Zanfagnin, Xiaonan Hou, Nathan R. Foster, Erik Asmus, Andrea E. Wahner Hendrickson, Aminah Jatoi, Matthew S. Block, Carrie L. Langstraat...> ;ESMO open. 2020 Oct 1
• Peptide vaccine with glucopyranosyl lipid A-stable oil-in-water emulsion for patients with resected melanoma.
  Eric P Grewal, Courtney L Erskine, Wendy K. Nevala, Jacob B Allred, Carrie A Strand, Lisa A. Kottschade, Robert R. McWilliams, Roxana S. Dronca, Adam J Yakovich, Sveto...> ;Immunotherapy. 2020 Aug 5
• 2 citations
  Chemo-immunotherapy combination after PD-1 inhibitor failure improves clinical outcomes in metastatic melanoma patients
  Jesus Vera Aguilera, Jonas Paludo, Robert R. McWilliams, Henan Zhang, Ying Li, Anagha Bangalore Kumar, Jarrett J. Failing, Lisa A. Kottschade, Matthew S. Block, Svetom...> ;Melanoma Research. 2020 Aug 1
• Frailty is a determinant of suboptimal chemotherapy in women with advanced ovarian cancer.
  Deepa Maheswari Narasimhulu, Michaela E. McGree, Amy L. Weaver, Aminah Jatoi, Nathan K. LeBrasseur, Gretchen E. Glaser, Carrie L. Langstraat, Matthew S. Block, Amanika...> ;Gynecologic Oncology. 2020 Jun 6
• HLA class-I and class-II restricted neoantigen loads predict overall survival in breast cancer
  Yingxue Ren, Yesesri Cherukuri, Daniel P. Wickland, Vivekananda Sarangi, Shulan Tian, Jodi M. Carter, Aaron S. Mansfield, Matthew S. Block, Mark E. Sherman, Keith L. K...> ;OncoImmunology. 2020 Apr 1
• Sex-Based Differences in Melanoma Survival in a Contemporary Patient Cohort.
  Tina J. Hieken, Amy E. Glasgow, Elizabeth Ann L. Enninga, Lisa A. Kottschade, Roxana S. Dronca, Svetomir N. Markovic, Matthew S. Block, Elizabeth B. Habermann> ;Journal of Womens Health. 2020 Feb 27
• 12 citations
  First-in-Class, First-in-Human Study Evaluating LV305, a Dendritic-Cell Tropic Lentiviral Vector, in Sarcoma and Other Solid Tumors Expressing NY-ESO-1
  Neeta Somaiah, Matthew S. Block, Joseph Kim, Geoffrey I. Shapiro, Khanh Do, Patrick Hwu, Joseph Paul Eder, Robin L. Jones, Hailing Lu, Jan ter Meulen, Chet Bohac, Mich...> ;Clinical Cancer Research. 2019 Oct 1
• 3 citations
  A pilot clinical trial testing topical resiquimod and a xenopeptide as immune adjuvants for a melanoma vaccine targeting MART-1.
  Matthew S. Block, Wendy K. Nevala, Yuan Ping Pang, Jacob B. Allred, Carrie Strand, Svetomir N. Markovic> ;Melanoma Research. 2019 Aug 1
• Case series of dabrafenib-trametinib-induced pyrexia successfully treated with colchicine.
  Jesus Vera, Jonas Paludo, Lisa A. Kottschade, Jessica Brandt, Yiyi Yan, Matthew S. Block, Robert R. McWilliams, Roxana S. Dronca, Charles L. Loprinzi, Axel Grothey, Sv...> ;Supportive Care in Cancer. 2019 Feb 14
• Immune checkpoint inhibitors: an emerging cause of insulin-dependent diabetes.
  Anupam Kotwal, Candace L. Haddox, Matthew S. Block, Yogish C. Kudva> ;BMJ open diabetes research & care. 2019 Feb 1
• The evolving clinical landscape for dendritic cell vaccines and cancer immunotherapy.
  Martin J. Cannon, Matthew S. Block, Lauren C. Morehead, Keith L. Knutson> ;Immunotherapy. 2019 Feb 1
• The role of serum lactate dehydrogenase level as a prognostic indicator in resected, high risk melanoma
  Anagha Bangalore Kumar, Jesus Vera Aguilera, Ana I. Velazquez, Yiyi Yan, James W. Jakub, Jerry D. Brewer, Tina J. Hieken, Matthew S. Block, Robert R. McWilliams, Clark...> ;Dermatologic Therapy. 2019 Jan 1
• Management of local or regional non-nodal disease.
  Jennifer M. Racz, Matthew S. Block, Christian L. Baum, James W. Jakub> ;Journal of Surgical Oncology. 2019 Jan 1
• Peptide-Binding Groove Contraction Linked to the Lack of T Cell Response: Using Complex Structure and Energy To Identify Neoantigens.
  Yuan Ping Pang, Laura R. Elsbernd, Matthew S. Block, Svetomir N. Markovic> ;ImmunoHorizons. 2018 Aug 1
• Folate Receptor Alpha Peptide Vaccine Generates Immunity in Breast and Ovarian Cancer Patients.
  Kimberly R. Kalli, Matthew S. Block, Pashtoon Murtaza Kasi, Courtney L. Erskine, Timothy J. Hobday, Allan B. Dietz, Douglas J. Padley, Michael P. Gustafson, Barath Shr...> ;Clinical Cancer Research. 2018 Jul 1
• Integrative Genome-Wide Analysis of Long Noncoding RNAs in Diverse Immune Cell Types of Melanoma Patients.
  Wang, L., Felts, S. J., Van Keulen, V. P., Scheid, A. D., Block, M. S., Markovic, S. N., Pease, L. R., Zhang, Y.> ;Cancer research. 2018 Jun 14
• 4 citations
  Neoadjuvant systemic therapy for regionally advanced melanoma
  James W. Jakub, Jennifer M. Racz, Tina J. Hieken, Alexandra B. Gonzalez, Lisa A. Kottschade, Svetomir N. Markovic, Yiyi Yan, Matthew S. Block> ;Journal of Surgical Oncology. 2018 May 1
• MyD88 and TLR4 expression in epithelial ovarian cancer
  Matthew S. Block, Robert A. Vierkant, Peter F Rambau, Stacey J. Winham, Philipp Wagner, Nadia Traficante, A. Toloczko, Daniel Guimarães Tiezzi, Florin Andrei Taran, Pe...> ;Mayo Clinic proceedings. 2018 Mar 1
• 32 citations
  Dose-Response Association of CD8(+) Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer
  Ellen L. Goode, Matthew S. Block, Kimberly R. Kalli, Robert A. Vierkant, Wenqian Chen, Zachary C. Fogarty, Aleksandra Gentry-Maharaj, A. Toloczko, Alexander Hein, Alie...> ;JAMA Oncology. 2017 Dec 1
• IL10 release upon PD-1 blockade sustains immunosuppression in ovarian cancer
  Purushottam Lamichhane, Lavakumar Karyampudi, Barath Shreeder, James Krempski, Deborah Bahr, Joshua Daum, Kimberly R. Kalli, Ellen L. Goode, Matthew S. Block, Martin J...> ;Cancer Research. 2017 Dec 1
• 3 citations
  Association between the use of surveillance PET/CT and the detection of potentially salvageable occult recurrences among patients with resected high-risk melanoma.
  Roberto A. Leon-Ferre, Lisa A. Kottschade, Matthew S. Block, Robert R. McWilliams, Roxana S. Dronca, Edward T. Creagan, Jacob B. Allred, Val J. Lowe, Svetomir N. Markovic> ;Melanoma Research. 2017 Aug 1
• 7 citations
  Inflammatory and Nutritional Serum Markers as Predictors of Peri-operative Morbidity and Survival in Ovarian Cancer.
  Amanika Kumar, Michelle Torres, William A. Cliby, Kimberly R. Kalli, Giorgio Bogani, Giovanni Aletti, C.C. Nitschmann, Francesco Multinu, Amy L. Weaver, Matthew S. Blo...> ;Anticancer Research. 2017 Jul 1
• Join now to see all